Abstract: Provided is a compound of formula I or II, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and the medical uses thereof in treating diseases benefiting from the capsid protein assembly inhibitor, particularly diseases caused by hepatitis B virus infection.

Abstract: This application relates to the field of communication technologies, and provides a sensing method and an apparatus. An example method includes: A first node determines a target distance, where the target distance is a distance between the first node and a second node; the first node receives target information from the second node, where the target information includes location information of a first reflector and/or location information of a second reflector, the first reflector is a reflector closest to the second node, the second reflector is a reflector with a largest deflection angle relative to a direction of a target signal, and the target signal is a signal sent by the first node to the second node; the first node determines a first resource based on the target distance and the target information; and the first node senses the second node by using the first resource.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: The present application belongs to the field of pharmaceutical chemistry, and relates to a furo[3,4-b]pyrrole-containing BTK inhibitor, and in particular, to a compound of formula (I), a stereisomer or pharmacologically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition containing the compound, and use thereof in treating BTK-related diseases.

Abstract: The present disclosure relates to a charging system, a foreign object detection method and component, and a charging control method and device, which belong to the wireless technical field. The foreign object detection method includes receiving a voltage value and a current value of the transmitting coil, and determining a mutual inductance value of the transmitting coil according to the voltage value and the current value of the transmitting coil; receiving a voltage value and a current value of the receiving coil, and determining a mutual inductance value of the receiving coil according to the voltage value and the current value of the receiving coil; and determining whether there is a conductor foreign object between the receiving coil and the transmitting coil according to the mutual inductance value of the transmitting coil and the mutual inductance value of the receiving coil.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: The present disclosure relates to a charging system, a foreign object detection method and component, and a charging control method and device, which belong to the wireless technical field. The foreign object detection method includes receiving a voltage value and a current value of the transmitting coil, and determining a mutual inductance value of the transmitting coil according to the voltage value and the current value of the transmitting coil; receiving a voltage value and a current value of the receiving coil, and determining a mutual inductance value of the receiving coil according to the voltage value and the current value of the receiving coil; and determining whether there is a conductor foreign object between the receiving coil and the transmitting coil according to the mutual inductance value of the transmitting coil and the mutual inductance value of the receiving coil.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: A bone repair material, a preparation method of the bone repair material, and a biological composite scaffold are provided. The bone repair material includes: a base material, and a carbon nanomaterial and a polypeptide both mixed with the base material; and the carbon nanomaterial and the polypeptide are bonded by chemical bonds. The preparation method includes: bonding a carbon nanomaterial with a polypeptide by chemical bonds; and mixing the carbon nanomaterial and the polypeptide bonded by the chemical bonds with a base material, and performing a molding treatment.

Abstract: Provided is a compound of formula I or II, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and the medical uses thereof in treating diseases benefiting from the capsid protein assembly inhibitor, particularly diseases caused by hepatitis B virus infection.

Abstract: The disclosure relates to the technical field of display, and provides a flexible display screen, a method for deformably driving the same, and a display device. The flexible display screen includes a flexible display panel and a deformable driver disposed on a back surface of the flexible display panel. The deformable driver drives the flexible display panel to deform based on the electrodeformation. The deformable driver includes a plurality of deformable units arranged in an array. The flexible display screen can achieve deformation with a variety of degrees of freedom, and can precisely control the deformation, thereby easy to achieve ultra-thin screen design.

Abstract: The present application belongs to the field of pharmaceutical chemistry, and relates to a furo[3,4-b]pyrrole-containing BTK inhibitor, and in particular, to a compound of formula (I), a stereisomer or pharmacologically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition containing the compound, and use thereof in treating BTK-related diseases.

Abstract: A bone repair material, a preparation method of the bone repair material, and a biological composite scaffold are provided. The bone repair material includes: a base material, and a carbon nanomaterial and a polypeptide both mixed with the base material; and the carbon nanomaterial and the polypeptide are bonded by chemical bonds. The preparation method includes: bonding a carbon nanomaterial with a polypeptide by chemical bonds; and mixing the carbon nanomaterial and the polypeptide bonded by the chemical bonds with a base material, and performing a molding treatment.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: The present application discloses a wireless charging device. The wireless charging device comprises: a portable container, the portable container being provided with an induction coil and a mounting base for mounting a mobile device, when the mobile device is mounted in the mounting base, the induction coil and the mobile device forming a closed loop; and a wireless charging terminal, the wireless charging terminal comprising an electrified coil, the electrified coil being electrified with an alternating current so as to generate a magnetic field, when the induction coil is located in the magnetic field, an induction current will be generated in the induction coil and the mobile device can be charged.

Abstract: An embodiment of the present disclosure provides a welding fixture, including: a base; a supporter; a fixing device arranged to fix a member to be welded on the supporter; and a damping hinge which includes a first hinge plate, a second hinge plate and a pivot, the first hinge plate being fixed to the base, the second hinge plate being fixed to the supporter, wherein each of the first hinge plate and the second hinge plate has a pivot hole and is connected to the pivot via the pivot hole, and wherein the pivot is fitted into the pivot hole of each of the first hinge plate and the second hinge plate by interference. An embodiment of the present disclosure provides a welding method using the welding fixture.

Abstract: The present application provides a health monitoring method, a wearable device, a health monitoring system, and a computer readable storage medium. The health monitoring method includes: acquiring pregnant woman health reference information; transmitting the pregnant woman health reference information and pregnant woman identity information in the wearable device to a remote medical server terminal; and receiving pregnant woman health diagnosis information from the remote medical server terminal, wherein the pregnant woman health diagnosis information is determined according to the pregnant woman health reference information and the pregnant woman identity information.

Abstract: The present application discloses a wireless charging device. The wireless charging device comprises: a portable container, the portable container being provided with an induction coil and a mounting base for mounting a mobile device, when the mobile device is mounted in the mounting base, the induction coil and the mobile device forming a closed loop; and a wireless charging terminal, the wireless charging terminal comprising an electrified coil, the electrified coil being electrified with an alternating current so as to generate a magnetic field, when the induction coil is located in the magnetic field, an induction current will be generated in the induction coil and the mobile device can be charged.

Abstract: The disclosure relates to the technical field of display, and provides a flexible display screen, a method for deformably driving the same, and a display device. The flexible display screen includes a flexible display panel and a deformable driver disposed on a back surface of the flexible display panel. The deformable driver drives the flexible display panel to deform based on the electrodeformation. The deformable driver includes a plurality of deformable units arranged in an array. The flexible display screen can achieve deformation with a variety of degrees of freedom, and can precisely control the deformation, thereby easy to achieve ultra-thin screen design.

Abstract: An embodiment of the present disclosure provides a welding fixture, including: a base; a supporter; a fixing device arranged to fix a member to be welded on the supporter; and a damping hinge which includes a first hinge plate, a second hinge plate and a pivot, the first hinge plate being fixed to the base, the second hinge plate being fixed to the supporter, wherein each of the first hinge plate and the second hinge plate has a pivot hole and is connected to the pivot via the pivot hole, and wherein the pivot is fitted into the pivot hole of each of the first hinge plate and the second hinge plate by interference. An embodiment of the present disclosure provides a welding method using the welding fixture.